Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
2.98
Dollar change
-0.02
Percentage change
-0.60
%
Index- P/E- EPS (ttm)- Insider Own8.01% Shs Outstand8.26M Perf Week-2.93%
Market Cap24.61M Forward P/E- EPS next Y-2.86 Insider Trans0.00% Shs Float7.60M Perf Month0.68%
Income- PEG- EPS next Q-0.99 Inst Own54.91% Short Float2.35% Perf Quarter17.79%
Sales- P/S- EPS this Y86.16% Inst Trans-33.80% Short Ratio14.40 Perf Half Y-7.17%
Book/sh4.55 P/B0.66 EPS next Y-56.75% ROA- Short Interest0.18M Perf Year-46.40%
Cash/sh1.72 P/C1.73 EPS next 5Y- ROE- 52W Range2.08 - 7.40 Perf YTD19.20%
Dividend Est.- P/FCF- EPS past 5Y-0.70% ROI- 52W High-59.73% Beta0.80
Dividend TTM- Quick Ratio2.11 Sales past 5Y6.09% Gross Margin- 52W Low43.27% ATR (14)0.10
Dividend Ex-Date- Current Ratio2.11 EPS Y/Y TTM-60.01% Oper. Margin-682.44% RSI (14)46.84 Volatility1.43% 2.76%
Employees76 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom2.33 Target Price3.53
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q44.84% Payout- Rel Volume0.14 Prev Close3.00
Sales Surprise37.28% EPS Surprise19.67% Sales Q/Q-79.25% EarningsNov 09 BMO Avg Volume12.38K Price2.98
SMA20-0.71% SMA50-2.01% SMA200-11.66% Trades Volume1,766 Change-0.60%
Date Action Analyst Rating Change Price Target Change
May-24-22Downgrade Stephens Overweight → Equal-Weight
Mar-14-22Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jan-07-22Initiated Stephens Overweight $3.10
Jan-06-22Resumed Piper Sandler Overweight $3.10
Mar-17-21Resumed Needham Buy $8
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy $6
Dec-16-20Upgrade Piper Sandler Neutral → Overweight $2 → $4
Nov-30-20Initiated BTIG Research Buy $5
Nov-10-20Initiated KeyBanc Capital Markets Overweight $5
Jul-30-20Reiterated The Benchmark Company Speculative Buy $7 → $6
Jan-16-24 08:00AM
Dec-06-23 08:00AM
Nov-09-23 08:27AM
07:00AM
Nov-03-23 08:30AM
08:00AM Loading…
Sep-18-23 08:00AM
Sep-06-23 08:00AM
Aug-28-23 08:30AM
Aug-10-23 07:00AM
Aug-09-23 08:00AM
Aug-08-23 08:30AM
Aug-03-23 08:00AM
Jul-25-23 09:08AM
Jul-24-23 01:35PM
Jun-27-23 08:30AM
04:15PM Loading…
Jun-01-23 04:15PM
May-11-23 08:00AM
Apr-27-23 04:59PM
Apr-18-23 08:45AM
Apr-12-23 04:15PM
Apr-07-23 08:24AM
Apr-03-23 08:00AM
Mar-31-23 05:00PM
Mar-29-23 04:01PM
Mar-15-23 04:01PM
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Dec-16-22 08:19AM
08:00AM
Nov-30-22 06:05PM
06:00PM Loading…
06:00PM
Nov-10-22 04:30PM
Oct-27-22 04:01PM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-31-22 04:01PM
Aug-30-22 04:27PM
Aug-24-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 04:01PM
Aug-01-22 11:33AM
05:00AM
Jul-27-22 04:01PM
Jul-13-22 08:00AM
Jul-06-22 08:00AM
Jun-22-22 08:00AM
Jun-15-22 07:15AM
May-26-22 05:00PM
May-11-22 04:05PM
May-05-22 08:00AM
Apr-28-22 04:01PM
Apr-27-22 04:30PM
Apr-22-22 09:26AM
Apr-13-22 10:01PM
05:12PM
05:10PM
Apr-11-22 08:00AM
Mar-28-22 08:00AM
Mar-10-22 04:05PM
Mar-01-22 04:05PM
Feb-21-22 07:26AM
Feb-10-22 08:00AM
Jan-18-22 04:05PM
Jan-06-22 09:43AM
Jan-04-22 08:00AM
Dec-09-21 06:00PM
Dec-08-21 08:00AM
Dec-06-21 08:00AM
Dec-02-21 08:00AM
Nov-22-21 06:14AM
Nov-09-21 04:05PM
Nov-04-21 08:00AM
Nov-02-21 03:02PM
Oct-27-21 08:00AM
Oct-26-21 04:05PM
Oct-08-21 09:46AM
Oct-07-21 08:00AM
Sep-30-21 08:00AM
Sep-20-21 11:35AM
08:00AM
Sep-16-21 08:00AM
Sep-13-21 08:00AM
Sep-07-21 04:05PM
Aug-23-21 09:13AM
Aug-18-21 08:49AM
Aug-17-21 08:00AM
Aug-10-21 04:01PM
Aug-09-21 08:00AM
Aug-03-21 03:00PM
Jul-27-21 10:35AM
Jul-08-21 05:34AM
Jun-22-21 08:00AM
Jun-15-21 08:03AM
Jun-03-21 08:00AM
Jun-01-21 08:00AM
May-24-21 05:26AM
May-17-21 04:01PM
02:45PM
May-06-21 08:00AM
May-04-21 04:01PM
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KINGSLEY ALFRED DDirectorJun 14 '23Buy0.2130,0006,447469,111Jun 15 08:13 PM
PURA VIDA INVESTMENTS, LLC10% OwnerApr 05 '23Buy0.30663,000200,0278,090,202Apr 07 05:12 PM
BROADWOOD PARTNERS, L.P.10% OwnerApr 03 '23Buy0.3026,827,6388,093,89850,181,335Apr 05 09:35 PM